These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 707519)

  • 21. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis.
    Millman S; Strauss AL; Parks JH; Coe FL
    Kidney Int; 1982 Oct; 22(4):366-70. PubMed ID: 7176335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.
    Coe FL; Kavalach AG
    N Engl J Med; 1974 Dec; 291(25):1344-50. PubMed ID: 4610395
    [No Abstract]   [Full Text] [Related]  

  • 26. Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.
    Meyer JL
    Invest Urol; 1981 Nov; 19(3):197-201. PubMed ID: 7298292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The uric acid: cystine correlation in the urine of recurrent calcium oxalate stone-formers and healthy controls.
    Leskovar P; Hartung R; Kratzer M
    Adv Exp Med Biol; 1980; 122A():115-9. PubMed ID: 7191616
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hyperuricosuric calcium oxalate stone former.
    Sarig S
    Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of crystalluria as a method of evaluation of preventive medical treatment of renal calculosis].
    Buli P; Pulini V; Platania A; Petrone U; Brunocilla E; Martorelli M
    Minerva Urol; 1982; 34(3):137-50. PubMed ID: 7177065
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
    Arowojolu O; Goldfarb DS
    J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary urate and uric acid relative saturation in normouricuric calcium oxalate stone formers with normal urinary calcium oxalate saturation.
    Labeeuw M; Gerbaulet C; Pozet N; Zech P; Traeger J
    Adv Exp Med Biol; 1980; 122A():87-92. PubMed ID: 7424663
    [No Abstract]   [Full Text] [Related]  

  • 34. Uric acid/calcium oxalate nephrolithiasis. Clinical and biochemical findings in 86 patients.
    Rapado A; Castrillo JM; Diaz-Curiel M; Traba ML; Santos M; Cifuentes-Delatte L
    Adv Exp Med Biol; 1980; 122A():109-13. PubMed ID: 7424622
    [No Abstract]   [Full Text] [Related]  

  • 35. [Degree of saturation of urine with calcium oxalate in patients with metabolically active calcium-oxalate urolithiasis].
    Głuszek J; Raszeja-Wanic B; Pupek-Musialik D; Luzna B
    Pol Tyg Lek; 1979 Nov; 34(46):1777-9. PubMed ID: 575672
    [No Abstract]   [Full Text] [Related]  

  • 36. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers.
    Coe FL; Moran E; Kavalich AG
    J Chronic Dis; 1976 Dec; 29(12):793-800. PubMed ID: 1010873
    [No Abstract]   [Full Text] [Related]  

  • 37. Implications of disorders of purine metabolism for the kidney and the urinary tract.
    de Vries A; Sperling O
    Ciba Found Symp; 1977; (48):179-206. PubMed ID: 24529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [EXPERIENCE OF USE OF BLEMAREN® IN THE TREATMENT OF PATIENTS IN URIC ACID AND CALCIUM OXALATE UROLITHIASIS].
    Konstantinova OV; Yanenko EK
    Urologiia; 2015; (5):22-4, 26. PubMed ID: 26859932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors.
    Pieras E; Costa-Bauzá A; Ramis M; Grases F
    ScientificWorldJournal; 2006 Apr; 6():2411-9. PubMed ID: 17619710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.